Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.

Koehler NK, Stransky E, Shing M, Gaertner S, Meyer M, Schreitmüller B, Leyhe T, Laske C, Maetzler W, Kahle P, Celej MS, Jovin TM, Fallgatter AJ, Batra A, Buchkremer G, Schott K, Richartz-Salzburger E.

PLoS One. 2013 May 31;8(5):e64649. doi: 10.1371/journal.pone.0064649. Print 2013.

PMID:
23741358
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.

Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A, Gasser T, Hörnig S, Langkamp M.

J Alzheimers Dis. 2011;26(1):171-9. doi: 10.3233/JAD-2011-110221.

PMID:
21593566
[PubMed - indexed for MEDLINE]
3.

Decreased α-synuclein serum levels in patients with Lewy body dementia compared to Alzheimer's disease patients and control subjects.

Laske C, Fallgatter AJ, Stransky E, Hagen K, Berg D, Maetzler W.

Dement Geriatr Cogn Disord. 2011;31(6):413-6. doi: 10.1159/000329763. Epub 2011 Jul 13.

PMID:
21757905
[PubMed - indexed for MEDLINE]
4.

α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.

Quinn JG, Coulson DT, Brockbank S, Beyer N, Ravid R, Hellemans J, Irvine GB, Johnston JA.

Brain Res. 2012 Jun 12;1459:71-80. doi: 10.1016/j.brainres.2012.04.018. Epub 2012 Apr 17.

PMID:
22560502
[PubMed - indexed for MEDLINE]
5.

Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease.

Kasuga K, Tokutake T, Ishikawa A, Uchiyama T, Tokuda T, Onodera O, Nishizawa M, Ikeuchi T.

J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):608-10. doi: 10.1136/jnnp.2009.197483.

PMID:
20522869
[PubMed - indexed for MEDLINE]
6.

CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.

Noguchi-Shinohara M, Tokuda T, Yoshita M, Kasai T, Ono K, Nakagawa M, El-Agnaf OM, Yamada M.

Brain Res. 2009 Jan 28;1251:1-6. doi: 10.1016/j.brainres.2008.11.055. Epub 2008 Nov 28.

PMID:
19071095
[PubMed - indexed for MEDLINE]
7.

Altered CSF orexin and α-synuclein levels in dementia patients.

Wennström M, Londos E, Minthon L, Nielsen HM.

J Alzheimers Dis. 2012;29(1):125-32. doi: 10.3233/JAD-2012-111655.

PMID:
22207004
[PubMed - indexed for MEDLINE]
8.

Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobe.

Mukaetova-Ladinska EB, Xuereb JH, Garcia-Sierra F, Hurt J, Gertz HJ, Hills R, Brayne C, Huppert FA, Paykel ES, McGee MA, Jakes R, Honer WG, Harrington CR, Wischik CM.

ScientificWorldJournal. 2009 Dec 16;9:1463-75. doi: 10.1100/tsw.2009.151.

PMID:
20024519
[PubMed - indexed for MEDLINE]
Free Article
9.

Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.

Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E.

PLoS One. 2010 Feb 19;5(2):e9313. doi: 10.1371/journal.pone.0009313.

PMID:
20174468
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy.

Wennström M, Surova Y, Hall S, Nilsson C, Minthon L, Boström F, Hansson O, Nielsen HM.

PLoS One. 2013;8(1):e53250. doi: 10.1371/journal.pone.0053250. Epub 2013 Jan 8.

PMID:
23308173
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.

Paleologou KE, Kragh CL, Mann DM, Salem SA, Al-Shami R, Allsop D, Hassan AH, Jensen PH, El-Agnaf OM.

Brain. 2009 Apr;132(Pt 4):1093-101. doi: 10.1093/brain/awn349. Epub 2009 Jan 20.

PMID:
19155272
[PubMed - indexed for MEDLINE]
Free Article
12.

Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes.

Mukaetova-Ladinska EB, Milne J, Andras A, Abdel-All Z, Cerejeira J, Greally E, Robson J, Jaros E, Perry R, McKeith IG, Brayne C, Xuereb J, Cleghorn A, Doherty J, McIntosh G, Milton I.

Dement Geriatr Cogn Disord. 2008;26(1):32-42. doi: 10.1159/000141039. Epub 2008 Jun 25.

PMID:
18577885
[PubMed - indexed for MEDLINE]
13.

CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease.

Reesink FE, Lemstra AW, van Dijk KD, Berendse HW, van de Berg WD, Klein M, Blankenstein MA, Scheltens P, Verbeek MM, van der Flier WM.

J Alzheimers Dis. 2010;22(1):87-95. doi: 10.3233/JAD-2010-100186.

PMID:
20847452
[PubMed - indexed for MEDLINE]
14.

The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.

Kapaki E, Paraskevas GP, Emmanouilidou E, Vekrellis K.

PLoS One. 2013 Nov 25;8(11):e81654. doi: 10.1371/journal.pone.0081654. eCollection 2013.

PMID:
24282614
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.

Yanamandra K, Gruden MA, Casaite V, Meskys R, Forsgren L, Morozova-Roche LA.

PLoS One. 2011 Apr 25;6(4):e18513. doi: 10.1371/journal.pone.0018513.

PMID:
21541339
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.

Muntané G, Dalfó E, Martinez A, Ferrer I.

Neuroscience. 2008 Apr 9;152(4):913-23. doi: 10.1016/j.neuroscience.2008.01.030. Epub 2008 Feb 5.

PMID:
18343584
[PubMed - indexed for MEDLINE]
17.

[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].

Orimo S.

Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. Review. Japanese.

PMID:
18386627
[PubMed - indexed for MEDLINE]
18.

[Cerebrospinal fluid and plasma biomarkers for dementia with lewy bodies].

Kasuga K, Ikeuchi T.

Brain Nerve. 2012 May;64(5):505-13. Review. Japanese.

PMID:
22570064
[PubMed - indexed for MEDLINE]
19.

Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.

Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte ET, Frosch M, Growdon J, McLean P, Hyman BT.

Acta Neuropathol. 2006 Feb;111(2):101-8. Epub 2006 Feb 16.

PMID:
16482476
[PubMed - indexed for MEDLINE]
20.

Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies.

Beyer K, Lao JI, Carrato C, Mate JL, López D, Ferrer I, Ariza A.

Neuropathol Appl Neurobiol. 2004 Dec;30(6):601-7.

PMID:
15541000
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk